Corbus Pharmaceuticals Holdings, Inc. CRBP
7.14
(0.31)
(4.16%)
as of 25 Sep
- Market cap
- $144.1M
- P/E
- 0.0×
Follow CRBP
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(55.65%) | (54.18%) | (66.70%) | (95.58%) | |
| (49.34%) | (48.47%) | (59.44%) | (80.85%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(74.42%) | (53.64%) | (67.33%) | (100.55%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(4.84) | (4.84) | (3.94) | (4.47) | |
Free Cash Flow |
(59.51) | (64.49) | (73.65) | (86.69) | |
Capital Expenditures |
— | 0.00 | (0.01) | (0.02) | |
| Other line items | |||||
Cash ROIC |
(30.30%) | (20.71%) | (27.79%) | (39.36%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.88 | 0.82 | 0.87 | 0.85 | |
Depreciation/Fixed assets |
(5.89) | (7.13) | (11.27) | (15.70) | |
Capex/Depreciation |
0.00 | 0.00 | 0.01 | 0.02 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.84) | (4.84) | (3.94) | (4.47) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates